COGT (Cogent Biosciences) FCF Margin %: 0.00% (As of Mar. 2026)


COGT Cogent Biosciences Inc COGT
25 GF Score
Price $37.81
! 3 Warning Signs
View Full Analysis

What is Cogent Biosciences FCF Margin %?

Cogent Biosciences COGT +4.13% 25 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates COGT with a GF Score™ of 25/100. The stock has 3 warning signs investors should review. Among 959 Biotechnology companies, Cogent Biosciences ranks worse than 104275.18% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Cogent Biosciences's Free Cash Flow for the three months ended in Mar. 2026 was $-87.33 Mil. Cogent Biosciences's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Cogent Biosciences's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Cogent Biosciences's current FCF Yield % is -4.43%.

The historical rank and industry rank for Cogent Biosciences's FCF Margin % or its related term are showing as below:


During the past 11 years, the highest FCF Margin % of Cogent Biosciences was -184.66%. The lowest was -455.47%. And the median was -339.41%.

COGT's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -84.65
* Ranked among companies with meaningful FCF Margin % only.

Cogent Biosciences FCF Margin % Related Terms

Cogent Biosciences FCF Margin % Historical Data

* Premium members only.

The historical data trend for Cogent Biosciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cogent Biosciences FCF Margin % Chart

Cogent Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Cogent Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

COGT vs SRRK, RYTM, PTCT: FCF Margin % Comparison

For the Biotechnology subindustry, Cogent Biosciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cogent Biosciences FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cogent Biosciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Cogent Biosciences's FCF Margin % falls into.


COGT
25GF Score
Cogent Biosciences Inc COGT
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cogent Biosciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Cogent Biosciences's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-265.998/0
= %

Cogent Biosciences's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-87.332/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Cogent Biosciences (COGT) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Cogent Biosciences and its competitors. According to the industry distribution chart, Cogent Biosciences ranks #999999 out of 959 companies in the Biotechnology industry.
Is Cogent Biosciences' FCF Margin % too high?
Cogent Biosciences' current FCF Margin % is 0.00%. Based on the distribution chart, Cogent Biosciences ranks #999999 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Cogent Biosciences has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Cogent Biosciences' FCF Margin % compare to SRRK and RYTM?
According to the Biotechnology industry distribution chart, Cogent Biosciences ranks #999999 out of 959 companies for FCF Margin %. This places Cogent Biosciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Cogent Biosciences and its competitors. Cogent Biosciences's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cogent Biosciences stock overvalued right now?
Cogent Biosciences (COGT) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Cogent Biosciences' overall GF Score™ is 25/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Cogent Biosciences (COGT), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cogent Biosciences Business Description

Address 275 Wyman Street, 3rd Floor, Waltham, MA, USA, 02451
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
25GF Score

Get the complete analysis for COGT

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$37.81
Price